Why Merck's Vaccine Exit Is Significant: Mammadova

and on Bloomberg dot com. Paul Sweeney here accompanied by Matt Miller from Berlin, Germany, again continued newsflow on the healthcare front as it relates to the virus vaccines, what's working, what's not working? To get the latest, we welcome Jalen Mamadova, Global sector lead for healthcare at Third Bridge, based in New York City. Jailn, thanks so much for joining us here. We got some news out here today about merk Uh that it's vaccine they're pulling, it's not working, and then

they kind of pulling back from that. How significant is that? Thanks so much for having me, And it's pretty significant given the low vaccine supply that we have and the inefficiencies on the logistics fronts for both in fact pers

and providers around the coal chain. For m R and AS is really increases our reliance on the expected positive redoubts from J and J and Novo backs, as well as some pipeline candidates like GSC, SINOFFI and some of the newer platforms that you haven't releasen the media cover as much like back starts, TABLET or CODA Genics, nasal vaccines, all of those now are going to start mattering. The other front is on mark, so they have pulled back

on the two. But it's important to also bear in mind that we should still be following a potential reformulation on the delivery front for their VSC platforms, So if you go from intramuscular to potentially intra nasle, you may still see some form of efficacy. The question then is how far behind is that put them on. Fiser and Maderna puts extreme pressure in terms of streamlining their manufacturing.

Reefs already seen hiccups in terms of you know, accommodating for temperature controlled environments and modernist booster, which will add as a third regiment to be completely protective from the

news strains, will be more and more important. On the upside, though we've seen some loss and scheme on attention in terms of the neutralizing antibody molecules from Lily and the genera on those are going to probably come back, and we'll see more and more adoption of those as well as therapeutic products, which is the anti viral that the

work is working on. You know, we we've heard from so many people UM that this has been an inefficient rollout, although it seems so much more efficient than the last time we vaccinated the entire world in a handful of months. I wonder what you think UM needs to be improved and if you have optimism that it will be. I do have optimism, and so Biden's bands can technically work, right, We're already on the path of the news during a

million a day, you can even double that number. But all of this is going to be predicated on seeing some form of federal guidance and financing for both providers and manufactors. So take the provider site, that's a huge

trick up. We don't have the medical staffing. Sub eight storage is probably going to be even more important now with Mark falling out of the race, at least in the New York term, helping them resupply their dry ice, which they either have to do on their own or both state and expanding their infrastructure on the manufacturing site. In order for Biden's plan to work, you need seven point five million production a week for the next nine to ten weeks between Siser and Maderna for that to happen.

And you need some assistance on the shipping and container companies as well as distribution mechanisms with with McKesson. All in all, we need a central distribution system in the US that helps accommodates for the sub eight storage and those special containers. Assistance for companies like Sterling Ultracold that are working on coaching solutions UH to enable the use of mobile clinics that are really going to become important

in the next few months. So Jaalen, A lot of things need to fall into place, A lot of things need to happen that you just enumerated. How confident are you that this administration can get it done in a reasonable period of time? I this year, I'm confident because the tone has changed, right, it's a it's a more our experts are confident will say it this way because the tone has changed. But I do have to say

operation work speed. The previous administration, it did put a lot of the involves the seeds into place that needed to happen for Biden's plan to work, So we shouldn't dismiss that. And our experts see that there have been a lot of progress made with operational work, see that would even make the hundred millions possible in a hundred days.

But the tone of the Biden administration has changed and we are more confident, are experts are more confident that we will be seeing financing where it needs be in terms of having a convergence between even take federally owned material and commercially owned material across the four or five

pipeline candidates that are more near term. And then this week's before outstanding, you know, without sounding at all political, um, the Trump administrat had already ramped up vaccinations to a level that would achieve Biden's goals, right, I mean, by the time President Biden came into office, we were already vaccinating in the US almost a million people a day. So all he has to do is not do worse

then the Trump administration. The point that they had reached, is that really a concern for you that President Biden's administration will now do worse because of a lack of funding or production bottlenecks. So it's not so there's only so much that can happen at the federal level, which is why we bring it back to the financing component. The cold chain is not entirely developed in this country. I'm not even talking about the ultra culture cold chain,

ultra ultra you know, sub ad Storge. It's all going to come down to how stream lights the properties are at that level. Right with Mirk falling out and now that we have Fiser Madurnam potentially J and J, that still puts a lot of pressure on two of the most complicated logistically speaking, vaccine candidates where you're seeing increased

vaccine wastage. So that's where the issue is going to be with the Biden administration, not so much as you know, in comparing the two administrations, is not going to be so much in the implementation, but so much in Shakespeain the MAZE action funds, right, because if you look at the supply chain right hand, our focuses in streamlining, there's

manufacturing in efficiencies. That really comes down to UH financing in some form of federal guidance, and that's what's going to dictate whether or not the Biden administration will prove to be successful. And hey, j we have about thirty seconds left. The emerging markets, I mean the existing developed markets have their own challenge. Just talk to us about

the emerging markets. What's the plan there? The plan I mean COVID will probably in the low middle income countries will get vaccinated by your end we'll see in addition of by middle of next year and probably completion by two so that would be that would be the timeline. Jalen, thank you so much for joining us. We appreciate it always getting your thoughts to Jalen Momodova, Glomal sector lead

for healthcare for Third Bridge. So, mad, I guess the key issue here is obviously funding here in the States, uh, some central distribution um and then hopefully we can get you know, it's more out of you know, Johnson and Johnson. That's the next pharmaceutical company that we're really waiting on. Well, I think you make also an incredibly important point with your last question. You know, we've got to vaccinate the

whole world. So even if the US is successful, the UK, Germany and France, if you if you leave all of the rest of the countries in the world without vaccinations, then they just spread a new variant and you have a new problem. Yep, absolutely so um, as we heard from Jalen, Uh, that is probably not likely till two. So uh, this is going to be an issue for some time. But again, uh, the vaccines are getting out and hopefully they can be ramped up in terms of timing. Matt. Thanks,

what's for joining us today. We appreciate you. You're coming along. That was fun. Well, when we take a look at the large global airlines we saw the story of was a dramatic decline in passenger air travel commercially. How about on the private side. That's checking with Thomas Floor. He's a chairman and founder of Vistol Glober also the leader of the new private jet platform XO Thomas. Next, much

for joining us here. You know, I think you know a lot of our audience is certainly familiar when they look at the Uniteds of the world, the Deltas of the world, the European airlines saw dramatic declines in air travel. What happened to the private jet industry? Hey, how are you? Uh, very very good question. I mean, what do we really saw with the what I call the destruction of the commercial infrastructure is the fact that you know, the the the uh CEO is the chairman, the the the important

business leader around the globe. They still needed to travel and uh, we're not the ending on the load factor. So what happened was that the private jet industry really filled a gap and whilst overall travel was down, the addressable market has really uh multiplied in in in in the sense that there's a McKinsey study that up to people who can actually afford to fly on business sheds,

they never did. They used the commercial infrastructure, and um, that is really a traumatic shift where people were before, you know, and maybe we're offering demo flights to show people the time effectiveness of business judge were now actually paying for them that because that was the only way to get from a certain destination to another destination. I can understand that, especially during a pandemic, it's a lot

more attractive to fly private. UM. I flew commercial once during this pandemic and it's an experience that I never ever ever want to repeat. On the other hand, UM Thomas, there's been some events like Davos, which I'm sure must be a huge part of the private jet business. I mean, I look at the airfield there in Switzerland and see, you know, it seems like all of the private jets in the world go there once a year, and this

year they didn't. Can you feel something like that the cancelation of Davos UM well, look, I mean there is it's kind of like a very popular event and so therefore it's kind of like covered by the press. But the the the the the market is a lot bigger than just the Davos type of thing. People would make the example of Super Bowl and what have you. I can only look at our data and our data at at this the global which you know, you know, we

have the two brands. We have this the jet which really offers an alternative two aircraft ownership, and then we have the digital marketplace, which is flying so and at the flying level for example UM which sell memberships and so access to our fleet. We're seeing a three x in sign up of new members. And this is even if you compare Q two, which was the kind of like the center of the of the of the downturn of in due to COVID, we had over the year

before a three x wall members signing up. Because people want access to a to a world infrastructure which gets them from A to B. And and so what I'm saying and what I was seeing on before, is that yes, there is less line than zoom other technologies that really makes it possible day to communicate. But there is still a very very big activity of flights UH in demand today and that's what we are seeing in our traffic data and both at the Vistitute level as well as

at the as the Excel level. So Thomas, you talked about, so that that increases the demands that you saw last year. Give us a sense of kind of the breakdown between business versus personal slash leisure, because I think the expectation or the belief is that most of private jet aviation is business related m hm. And I think this is correct. I mean, if I had to give a more or less balanced break that, I'd say, it's it's still eight

business and twenty leisure. Um, it's it's before. Let's let's take somebody needed to go from from Boston to Desmond in the Midwest, and and maybe today you can get there, but you need to change the airport. So now you're having your your exposure, your your health exposure to three airports and two airplanes. And today you know a couple of executives get together and say, okay, well four people flying,

let's charter a plane. Uh go there in the morning, come back in the evening, having a safe travel bubble. And I think that's that's really one of the other drivery with that in the private jet industry, we're we're able to create these travel bubbles that everybody's tested from the driver taking you to the airplane. You're not going through a terminal building. You're actually pulling up in front of the airplane, and the pilots are tested and you go there at the pallets are not allowed to leave

the airplane. Look, there's there's no way it could be worse timas than commercial flight. I mean there's zero social distancing. You're shoved together like sardines and a bus from the airport to the plane, and then no one knows how to properly wear a mask. Let me ask you about the infrastructure because I've been watching the UH this signal takeover battle. UM it's a company that helps fuel private jets and provides passenger Medagine do you see UH this

market growing fast? I mean, does the infrastructure grow with the popular area in the demand. Yes, I mean we we have Look, I mean we went through and we have very clear signals internally here were we continue to expand. We we have more demand than we can fulfill on our own sleep. This such a day has a hundred thirty aircraft and we're planning to go to about one six because we're every day of the year we're about over subscribed and which we then need to sub charter

and hence this is this is the demand. So I think you're bought on. Overall people travel less, but the addressable market is so much bigger, and it was One other interesting thing is that Thomas and we're running out of time and we're gonna have to leave it there, but will certainly follow up with you on the private jet aviation industry experiencing some growth here. That's Thomas Floord, chairman and founder of Vista Global. Today we're joined by

Matt Miller from Berlin, Germany. Well, some active managers had quite in terms of performance. Our next guest is certainly one of them, Peter Anderson. He's the founder of Anderson Capital Management based in Boston. A return last year versus the SMP, A similar return actually in twenty nineteen as well. Let's get a s it's a kind of how he did it and what he's thinking about. Peter, thanks so much for joining us here. What were the winners for you last year? What worked for you? Well, you know,

I stuck to basics. I have to tell you that I've been doing this since Paul, and I will tell you that me was the most difficult year ever to invest. There were so many uncertainties. Of course the virus headlining that, and um I really didn't change any of my discipline. What I've tried to find our stocks that are common sense, uh, easy to understand situations, and so some of the top

performers actually were pet care stocks. I own a company called Trupanion, which is an insurance company health insurance company for animals. That stock has gone through the roof because the fundamentals are so appealing. Only one percent of pets out there are have health insurance. So can you imagine if we double just to two percent, that the revenues of that company with double. So it's things like that.

I tried to keep my eye on the center ring of this three ring circus to worry, and sometimes it takes a lot of discipline, but if you do, I think it does pay off. I have my dog Steve insured to the eye teeth. I mean he's insured if he breaks your stuff, he's insured if you break his stuff. Um, and of course if he needed anything beyond what insurance to pay for, I'd sell a car to pay for Steve. You are, yeah, well, yes, people will pay anything for

their pets, So that's a smart strategy, Pete. And congratulations on I mean, back to back plus gains is insanely good. But um, you know, does this keep working? Um? Can you? Can you still bet on these? Uh common sense value? Name as we as we bounce back from if we hopefully bounce back from pandemic. I would say with great courage, yes, it is more applicable now than it's ever been. And the reason I say that are there's so many um narratives out there now right about other types of industries,

say cryptocurrency, which compare that to say dog food. I mean, just as an extreme example, right, because I also own Fresh Pet, which is a animal food producer. But when you look at cryptocurrency, I have no idea how that works, and I at least have the courage to tell people that, you know, most people have only a superficial knowledge of how cryptocurrency works, yet they plow into that. So I think more than ever, we are tempted. You know, I was talking about a three ring circus and the other

two rings. There's a lot of things going on that can distract us from our main focus. One of them is cryptocurrency. Another one I inc and I know this is against most opinion out there, is the electric vehicle market. They're great cars, but they only they're less than five percent of the total addressable market. So we need to stay focused on this. And I think more than ever, common sense, simple to understand stories will win the day.

Peter's you know, I would say, since the September time frame, if you will, kind of a rotation trade in the equity markets from some of the tried and true big tech names that have led the way really since the financial crisis, the Amazons, the Apples of the world, into some more cyclical names. How do you view that trade? Well, I view that kind of the way most people are looking at, uh the big spending bill that the government is UH projecting and the stimulus all that, and that

does tie in with these rotations. However, I think timing those rotations is a fool's errand and I never tried to time markets like that. Of what I do is I say to myself, for instance, cyber security, is that a rotational type industry? Absolutely not, no matter what's going on in the country, if we're in a cyclical mode, uh, ben or value or growth, whatever however you want to call it. Cybersecurity names like Palo Alto and cyber Arc

are there to stay. They are endurable. Uh, They're durable companies that I think will surpass anything in terms of trying to time markets back and forth like that. If he you know, um, James Carvill used to say, if there were a reincarnation, he wanted to come back as the bond market because the bond market was the boss and everyone was afraid of the bond market. But um, that's really not the case. I even saw US debt financing costs are going to be the lowest they've been

in like four years this year. Um, is that going to stay that way? Because that's really been a huge tail wind. Fantastic points you're making, because of course, the other narrative out there now is uh, inflation, and people are very, very worried about interest rates going up, etcetera. And there's tons of work being done on that. And I think it's not as simple as most people think when they say, well, there's a stimulus plan that equals inflation,

that equals higher rates. I don't foresee rates increasing for the next two years, and I think that puts me on a very uh a minority group of talking about interest rates. But the common sense application of this again, I just go back to this, is that the FED is not going to make any movement right now because we have to recover from the virus. Hey, Peter, thank you so much for joining us. Always appreciate getting your thoughts.

Peter Anderson, founder of Anderson Capital Management, two years plus return. Certainly getting it right in the equity markets. A lot more coming up. Sweeney here, accompanied by Matt Miller from her in Germany. Let's take a look at the theater business. Um. You know, it's really obviously most of the theaters around the world have been closed since the beginning this pandemic, really crushing their balance sheets, and one of them, a MC the largest, is trying to shore up its balance sheet.

Cat Doherty joins us. She's a high yield distressed debt and bankruptcy reporter from Bloomberg News joined us on the phone. Kat talked to us about a MC again, the world's largest theater operator, really filling the pain of this pandemic and what it's done to theater tendance. What's it doing

with its balance sheet? Well, the latest today is just a string of actions that it's taken since the peak of the pandemic, when it saw a number of its theaters closed a majority um last spring, and now they've reopened about three hundred to four hundred of those in the US, but still they're seeing attendance at all time lows. So today they announced new financing that they secured. This

is a combination of debt and equity. They've been going to the equity markets to raise new capital and they're using that capital to try to get through the next few months, really looking for the summer when they're hoping the vaccine will be UM largely used and they'll see movie goers back in their seats. I don't know about you, but I will be the first person there. I mean when when they open back up. I used to go to the movies every week, you know. Um, and it's

killing me that I can't do any of this stuff. Uh. What does a m C say about their expected rebound. Well, they're hoping that a lot of their movie goers are just like you, that there is pent up demand and that there are many users viewers that want to be back in the seats of the theater seeing the movies on the big screen and not just at home. We've seen a lot of pressure even before the pandemic, with

consumers shifting to Netflix and other streaming services. UM, but others do want to see these movies, uh, in an experience that's unlike any other. UM, when you're seeing it in front of a big screen away from your home. UM. And I think that the pandemic has has just is accelerated a lot of those problems that they were seeing before. UM. But then again, it could also be creating this pent

up demand. It just remains to be seen. We're going to have to watch for um the openings, UM when certain states are lifting the limitations that are currently in place. And I guess another problem CAT is Okay, let's say you open up the theaters, is there going to be movies to actually see, we've seen a lot of the big studios, you know, kind of throwing in the talent and putting their you know, their their big movies, releasing them on their streaming services. So what's the future of

supply of quality content for these movie theaters? That's right. We've seen a number of delays UM toe into the summer. A lot are going straight to streaming services like HBO Max UM and every time that those announcements get made UM A, MC and other large cinema companies Regal Cinema's parent, UM, we see a reaction in the market, at least UM to whether or not it's going to affect UM consumer's decision to return and also UM whether or not, as you say, they'll be able to see content in the

theaters UM. So that's something that we're we're monitoring UM, and we're also looking to see what effects it might have on the media industry UM in Hollywood, whether UM the makers are going to be shifting to more permanent decisions that UM are going to impact cinemas, including AMC's ability to continue going forward. Yeah, you know, I've heard tales that Hollywood's power or was consolidated. UM amidst the Spanish flu because cinema couldn't be made overseas at the time.

And you have to wonder if now, um, you know that the the the base for making movies will shift away. You know, more and more people Tom Cruise is the example that I'm sure we all read about are making movies overseas because they just don't have the uh, the ability to do it in Hollywood. And I also wonder if there will be enough content. You know, it takes it takes a while to make a movie. You can't

do this in a week. So even after the vaccine, after we've got hurt immunity, it's not clear that everybody is going to be UM, you know, is going to have something and they can that's right. However, we've seen companies like Netflix UM that are announcing big plans to create content UM that's surpassing what they've done in the past. So there are situations that are showing that it's doable. UM that it's the limitation are there, but there's ways around it. A lot of these studios are having to

shoot but under major limitations. UM. They're having their actors go through testing UM daily and making sure that they can return to work and shoot for for future content, but under restrictions and making sure that they're doing this all um, you know, piecemeal, um and under the law. Hey Cat, thanks so much for joining us. We appreciate that Cat already high yield distressed debt and bankers reporter for Bloomberg News. Thanks for listening to Bloomberg Markets podcast.

You can subscribe and listen to interviews at Apple Podcasts or whatever podcast platform you prefer. I'm Bonnie Quinn. I'm on Twitter at Bonnie Quinn. And Paul Sweeney I'm on Twitter at p p Sweeney. Before the podcast, you can always catch us worldwide at Bloomberg Radio